Cosmetic
Surgical repositioning of descended midface tissues to restore cheek fullness, soften the tear trough, and smooth the lid-cheek junction.
Medically reviewed by Edward J. Wladis, MD, FACSOculoplastic SurgeonLast updated June 2026
Part of our complete guide to Upper Facial Aging — this page covers the midface lift in depth.
The midface — the region bounded by the lower eyelid above, the nasolabial fold medially, and the zygomatic arch laterally — is one of the first areas to betray facial aging. As the deep fat compartments of the cheek descend and lose volume, a cascade of changes appears around the eyes: the lid-cheek junction lengthens, a hollow tear trough develops, the lower eyelid appears longer, and a deepening nasojugal groove casts a perpetual shadow. A midface lift is a surgical procedure designed to reverse these changes by repositioning descended soft tissues back to their youthful position over the cheekbone, restoring the smooth, convex contour of a rejuvenated mid-face.
Oculoplastic surgeons are uniquely suited to perform midface surgery because the procedure directly affects the lower eyelid position, the tear trough, and the lid-cheek transition — structures that fall within the core training of ASOPRS fellowship. Midface lifting is frequently performed in combination with lower blepharoplasty, and the techniques used (transconjunctival access, SOOF elevation, fat repositioning) are extensions of standard eyelid surgery rather than separate disciplines.
Understanding midface anatomy is essential to appreciating why these procedures work. The midface is layered, from superficial to deep, as follows: skin, subcutaneous fat, the superficial musculoaponeurotic system (SMAS) continuous with the orbicularis oculi muscle, the suborbicularis oculi fat (SOOF), and finally the periosteum (the malar fat pad lies more superficially, in the subcutaneous plane) overlying the maxilla and zygoma.
Several anatomic ligaments tether the soft tissues to the underlying bone, including the orbicularis-retaining ligament (ORL), the zygomatic cutaneous ligaments, and the malar septum. With age, these retaining ligaments weaken and the soft tissue compartments descend in a predictable inferomedial vector. The tear trough is essentially the visible surface manifestation of a fixed ligamentous attachment at the medial orbital rim (the tear trough ligament, which continues laterally as the ORL): as the cheek fat falls away from this fixed attachment, a groove appears at the medial inferior orbital rim.
The SOOF (suborbicularis oculi fat) sits deep to the orbicularis muscle and superficial to the periosteum of the inferior orbital rim. Elevating and resuspending the SOOF is the central maneuver of most modern midface lifts, because it restores volume directly over the orbital rim where age-related hollowing is most apparent.
For a detailed walkthrough of the surrounding soft tissue planes, see our eyelid anatomy guide, which explains how the lower lid, orbicularis, and SOOF interact during aging and surgery.
Ideal candidates for midface lifting are patients in their mid-40s through 60s who demonstrate true tissue descent rather than isolated volume loss. The hallmark findings on examination include:
Patients with a negative vector orbit deserve special mention. These individuals are at elevated risk for lower lid malposition after traditional skin-muscle blepharoplasty, and adding a midface lift — which elevates and supports the lower lid from below — can be protective. Conversely, patients with primarily fat-related lower lid bags and minimal descent may do better with isolated blepharoplasty or non-surgical volume restoration.
There is no single “best” midface lift. The right approach depends on the degree of descent, the patient’s anatomy, whether blepharoplasty is being performed concurrently, and the surgeon’s training. The principal approaches used by oculoplastic surgeons are summarized below.
| Approach | Incision | Best For |
|---|---|---|
| Endoscopic | Temporal scalp + intraoral | Moderate to severe descent, younger patients with good skin |
| Transconjunctival | Inside lower lid | Mild to moderate descent with tear trough, combined with blepharoplasty |
| Subciliary / SOOF lift | Just below lash line | Patients also needing skin excision |
| Fat repositioning | Transconjunctival | Prominent fat bags with deep tear trough |
The endoscopic midface lift is the most powerful technique for true vertical repositioning of descended soft tissue. Through small incisions hidden in the temporal scalp (and sometimes a small intraoral incision in the gingivobuccal sulcus), the surgeon develops a plane along the deep temporal fascia and over the periosteum of the zygoma and maxilla. An endoscope provides illuminated visualization of structures including the zygomaticofacial neurovascular bundle and the frontal and zygomatic branches of the facial nerve, which must be protected.
Once the midface is freed from its bony attachments, the SOOF and malar fat pad are elevated in a vertical (or slightly superolateral) vector and fixated — typically to the deep temporal fascia using nonabsorbable suture or a bone tunnel through the lateral orbital rim. Because the lift vector is vertical rather than oblique, the result tends to look natural and helps avoid the “pulled” appearance that can follow lateral SMAS facelifts.
This approach is often paired with an endoscopic brow lift through the same temporal incisions, addressing the upper third of the face simultaneously. Recovery is longer than transconjunctival approaches because of the more extensive dissection.
The transconjunctival midface lift is the workhorse procedure for oculoplastic surgeons. Through an incision hidden inside the lower eyelid — the same access used for transconjunctival lower blepharoplasty — the surgeon accesses the inferior orbital rim, releases the orbicularis-retaining ligament and arcus marginalis, and elevates the SOOF off the maxillary periosteum.
The mobilized SOOF and adjacent soft tissues are then resuspended, most commonly with a suture passed through the inferior orbital rim periosteum or through a drill hole in the lateral orbital rim. The result is volumization directly over the rim, softening of the tear trough, and a shorter, smoother lid-cheek junction.
The advantages of this approach are significant: there is no external scar, dissection is limited, and recovery is comparatively rapid. Its main limitation is that it produces less dramatic elevation than the endoscopic approach — it is best thought of as a tear-trough-and-rim correction rather than a true facelift.
Two related techniques deserve individual discussion because they are frequently combined with lower blepharoplasty.
Fat repositioning has become a preferred technique among oculoplastic surgeons because it solves two problems simultaneously: it removes the bulge caused by herniated lower-lid fat and uses that same fat to fill the adjacent tear trough. The result is a single smooth contour from lash to cheek, rather than the “double bubble” that can occur when fat is excised aggressively over a deep trough.
In contemporary oculoplastic practice, midface lifting is most often performed alongside lower blepharoplasty rather than as a standalone operation. The synergy is anatomic: lower blepharoplasty addresses the eyelid component (excess skin, herniated fat) while the midface lift addresses the cheek component (descended SOOF, tear trough, lid-cheek junction). Treating both at once produces a unified, natural rejuvenation.
There is also a functional benefit. A well-performed SOOF lift or canthal resuspension provides upward support to the lower lid margin, reducing the risk of lower lid retraction, ectropion, and scleral show — the most common complications of aggressive lower blepharoplasty. For patients with a negative vector, prominent globe, or prior lid surgery, this combined approach is often the safest option.
Important: Patients who have already had lower blepharoplasty and now have scleral show, lid retraction, or a rounded lateral canthus may benefit dramatically from a secondary midface lift combined with canthoplasty. The midface lift recruits tissue from below to relieve downward tension on the lid.
Not every patient with midface aging is a surgical candidate — nor does every patient need surgery. Non-surgical approaches can achieve excellent results, particularly when the dominant problem is volume loss rather than true tissue descent.
Hyaluronic acid fillers are the mainstay of non-surgical midface rejuvenation. Cohesive, higher-G’ fillers (such as Restylane Lyft, Juvéderm Voluma, or RHA 4) are placed deeply over the zygoma and maxilla to restore lost projection. Softer fillers (Restylane, Belotero, RHA 2–3) can be used cautiously in the tear trough to camouflage the nasojugal groove. Filler injection around the eye carries rare but serious risks — including vascular occlusion causing skin damage or, very rarely, permanent vision loss — and should only be performed by an injector with deep knowledge of periorbital vascular anatomy. An important safety advantage of hyaluronic acid fillers is that they can be dissolved with an enzyme (hyaluronidase) if a contour problem or unwanted cosmetic result occurs. If a vascular occlusion is suspected, urgent high-dose hyaluronidase is the first-line emergency treatment and can often salvage the skin when given promptly; however, established vision loss is rarely reversible. Signs such as sudden pain, skin blanching or mottling, or any vision change after injection require immediate emergency treatment.
Biostimulatory injectables such as calcium hydroxylapatite (Radiesse) or poly-L-lactic acid (Sculptra) can be used to gradually rebuild cheek volume by stimulating native collagen formation. These products are longer-lasting than hyaluronic acid but are not reversible.
Energy-based skin tightening — radiofrequency microneedling, ultrasound (Ultherapy), or fractional laser — can improve skin quality and modestly tighten the midface, but they will not reposition descended fat. They are best thought of as adjuncts rather than substitutes for surgery.
A consultation with an oculoplastic surgeon helps determine whether filler alone, surgery, or a staged combination is right for you. Many patients begin with fillers in their 40s and transition to surgical lifting in their 50s or 60s as descent progresses.
Recovery after midface lift depends on the approach used. Transconjunctival procedures, with their limited dissection, typically involve 7–10 days of visible bruising and 2–3 weeks of swelling. Endoscopic midface lifts involve more extensive dissection and may require 2–3 weeks before patients feel ready to return to social activities, with subtle swelling lingering for 2–3 months.
Patients can expect:
Cold compresses, head elevation, and avoidance of strenuous exertion for two weeks help reduce swelling. Patients are often surprised that the cheek can feel slightly firm or “tight” for several weeks — this is the resuspended SOOF healing into its new position, and it relaxes over time.
Midface lifting is generally safe in experienced hands, but no surgery is without risk. Potential complications include:
Important: The most important predictor of a safe, natural-looking result is surgeon experience. Midface surgery requires detailed knowledge of orbital and facial anatomy — precisely the expertise of an ASOPRS-trained oculoplastic surgeon.
If you are considering midface rejuvenation — whether through surgery, fat repositioning, or filler — the best first step is a comprehensive consultation with a fellowship-trained oculoplastic surgeon who can evaluate your unique anatomy and recommend the right combination of procedures. Find an ASOPRS oculoplastic surgeon near you to discuss your goals and learn which approach will deliver the most natural, lasting result.
Related in-depth guides
Your Surgeon
Edward J. Wladis, MD, FACS
Ophthalmic Plastic Surgery PLLC
🏅 ASOPRS Fellowship Trained
Schedule a consultation with Edward J. Wladis, MD, FACS to learn if this procedure is right for you.
